| UniProt ID | PP1R8_HUMAN | |
|---|---|---|
| UniProt AC | Q12972 | |
| Protein Name | Nuclear inhibitor of protein phosphatase 1 | |
| Gene Name | PPP1R8 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 351 | |
| Subcellular Localization |
Nucleus. Nucleus speckle. Primarily, but not exclusively, nuclear. Isoform Gamma: Cytoplasm. Found mainly in the cytoplasm. |
|
| Protein Description | Inhibitor subunit of the major nuclear protein phosphatase-1 (PP-1). It has RNA-binding activity but does not cleave RNA and may target PP-1 to RNA-associated substrates. May also be involved in pre-mRNA splicing. Binds DNA and might act as a transcriptional repressor. Seems to be required for cell proliferation.; Isoform Gamma is a site-specific single-strand endoribonuclease that cleaves single strand RNA 3' to purines and pyrimidines in A+U-rich regions. It generates 5'-phosphate termini at the site of cleavage. This isoform does not inhibit PP-1. May be implicated in mRNA splicing.. | |
| Protein Sequence | MAAAANSGSSLPLFDCPTWAGKPPPGLHLDVVKGDKLIEKLIIDEKKYYLFGRNPDLCDFTIDHQSCSRVHAALVYHKHLKRVFLIDLNSTHGTFLGHIRLEPHKPQQIPIDSTVSFGASTRAYTLREKPQTLPSAVKGDEKMGGEDDELKGLLGLPEEETELDNLTEFNTAHNKRISTLTIEEGNLDIQRPKRKRKNSRVTFSEDDEIINPEDVDPSVGRFRNMVQTAVVPVKKKRVEGPGSLGLEESGSRRMQNFAFSGGLYGGLPPTHSEAGSQPHGIHGTALIGGLPMPYPNLAPDVDLTPVVPSAVNMNPAPNPAVYNPEAVNEPKKKKYAKEAWPGKKPTPSLLI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 19 (in isoform 2) | Phosphorylation | - | 6.53 | - | |
| 19 (in isoform 3) | Phosphorylation | - | 6.53 | - | |
| 25 (in isoform 3) | Phosphorylation | - | 67.51 | - | |
| 36 (in isoform 2) | Phosphorylation | - | 61.09 | - | |
| 40 | Acetylation | KGDKLIEKLIIDEKK ECCHHHHHHHCCCCC | 37.68 | 26822725 | |
| 40 (in isoform 3) | Phosphorylation | - | 37.68 | - | |
| 57 (in isoform 2) | Phosphorylation | - | 2.96 | - | |
| 62 (in isoform 2) | Phosphorylation | - | 4.49 | - | |
| 101 (in isoform 2) | Phosphorylation | - | 13.69 | - | |
| 107 (in isoform 2) | Phosphorylation | - | 59.65 | - | |
| 111 (in isoform 3) | Phosphorylation | - | 7.54 | - | |
| 120 | Phosphorylation | STVSFGASTRAYTLR CEEECCCCCCEEECC | 20.85 | 27251275 | |
| 121 | Phosphorylation | TVSFGASTRAYTLRE EEECCCCCCEEECCC | 20.84 | 27251275 | |
| 122 (in isoform 2) | Phosphorylation | - | 24.09 | - | |
| 124 | Phosphorylation | FGASTRAYTLREKPQ CCCCCCEEECCCCCC | 11.74 | 21406692 | |
| 125 | Phosphorylation | GASTRAYTLREKPQT CCCCCEEECCCCCCC | 20.53 | 24719451 | |
| 132 | Phosphorylation | TLREKPQTLPSAVKG ECCCCCCCCCCCCCC | 49.52 | 21406692 | |
| 135 | Phosphorylation | EKPQTLPSAVKGDEK CCCCCCCCCCCCCHH | 49.13 | 21406692 | |
| 138 | Sumoylation | QTLPSAVKGDEKMGG CCCCCCCCCCHHCCC | 61.43 | - | |
| 151 | Sumoylation | GGEDDELKGLLGLPE CCCCHHHHHHHCCCH | 45.52 | - | |
| 161 | Phosphorylation | LGLPEEETELDNLTE HCCCHHHHHHHHHHC | 45.16 | 9407077 | |
| 175 | Ubiquitination | EFNTAHNKRISTLTI CHHHHCCCCCEEEEE | 41.04 | - | |
| 178 | Phosphorylation | TAHNKRISTLTIEEG HHCCCCCEEEEEECC | 22.77 | 26055452 | |
| 179 | Phosphorylation | AHNKRISTLTIEEGN HCCCCCEEEEEECCC | 26.08 | 30576142 | |
| 181 | Phosphorylation | NKRISTLTIEEGNLD CCCCEEEEEECCCCC | 26.82 | 20068231 | |
| 193 (in isoform 2) | Phosphorylation | - | 73.13 | - | |
| 193 | Sumoylation | NLDIQRPKRKRKNSR CCCCCCCCCCCCCCC | 73.13 | - | |
| 199 | Phosphorylation | PKRKRKNSRVTFSED CCCCCCCCCCCCCCC | 31.03 | 25159151 | |
| 202 | Phosphorylation | KRKNSRVTFSEDDEI CCCCCCCCCCCCCCC | 21.97 | 29507054 | |
| 204 | Phosphorylation | KNSRVTFSEDDEIIN CCCCCCCCCCCCCCC | 30.65 | 25159151 | |
| 218 | Phosphorylation | NPEDVDPSVGRFRNM CHHHCCCCHHHHHHH | 32.51 | 27251275 | |
| 225 | Sulfoxidation | SVGRFRNMVQTAVVP CHHHHHHHEEEEEEE | 1.74 | 21406390 | |
| 228 | Phosphorylation | RFRNMVQTAVVPVKK HHHHHEEEEEEEEEC | 15.26 | 20068231 | |
| 234 | Acetylation | QTAVVPVKKKRVEGP EEEEEEEECCCCCCC | 46.65 | 25953088 | |
| 236 | Methylation | AVVPVKKKRVEGPGS EEEEEECCCCCCCCC | 56.83 | 116252631 | |
| 243 | Phosphorylation | KRVEGPGSLGLEESG CCCCCCCCCCCCCCC | 23.54 | 20068231 | |
| 249 | Phosphorylation | GSLGLEESGSRRMQN CCCCCCCCCCHHCEE | 32.47 | 20068231 | |
| 251 | Phosphorylation | LGLEESGSRRMQNFA CCCCCCCCHHCEEEE | 26.45 | 20068231 | |
| 264 | Phosphorylation | FAFSGGLYGGLPPTH EEECCCCCCCCCCCC | 16.66 | 11104670 | |
| 284 | O-linked_Glycosylation | QPHGIHGTALIGGLP CCCCCCCCEEECCCC | 12.25 | 28510447 | |
| 335 | Phosphorylation | NEPKKKKYAKEAWPG CCCCHHHCCHHHCCC | 31.61 | 10827081 | |
| 343 | Acetylation | AKEAWPGKKPTPSLL CHHHCCCCCCCCCCC | 52.04 | 25953088 | |
| 346 | Phosphorylation | AWPGKKPTPSLLI-- HCCCCCCCCCCCC-- | 34.10 | 23312004 | |
| 348 | Phosphorylation | PGKKPTPSLLI---- CCCCCCCCCCC---- | 37.98 | 28555341 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 161 | T | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 161 | T | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| 178 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 178 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 199 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
| 199 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
| 204 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
| 204 | S | Phosphorylation | Kinase | CK2_GROUP | - | PhosphoELM |
| 264 | Y | Phosphorylation | Kinase | LYN | P07948 | Uniprot |
| 335 | Y | Phosphorylation | Kinase | LYN | P07948 | PSP |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PP1R8_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "The C-terminus of NIPP1 (nuclear inhibitor of protein phosphatase-1)contains a novel binding site for protein phosphatase-1 that iscontrolled by tyrosine phosphorylation and RNA binding."; Beullens M., Vulsteke V., Van Eynde A., Jagiello I., Stalmans W.,Bollen M.; Biochem. J. 352:651-658(2000). Cited for: FUNCTION, MUTAGENESIS OF TYR-264; TYR-335; THR-346 AND SER-348, ANDPHOSPHORYLATION AT TYR-264 AND TYR-335. | |